A Narrative Literature Review Comparing the Key Features of Musculoskeletal Involvement in Rheumatoid Arthritis and Systemic Lupus Erythematosus Thomas DörnerEdward M. VitalGerd Burmester Review Open access 31 March 2022 Pages: 781 - 802
Residual Disease Associated with Suboptimal Treatment Response in Patients with Psoriatic Arthritis: A Systematic Review of Real-World Evidence Laura C. CoatesMaarten de WitAlexis R. Ogdie Review Open access 12 April 2022 Pages: 803 - 821
Patient Perception of Medical Care for Psoriatic Arthritis in North America and Europe: Results from a Global Patient Survey Pascal RichetteLaura C. CoatesMeriem Kessouri Original Research Open access 17 March 2022 Pages: 823 - 838
Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis Roy M. FleischmannAmy E. BockEva Dokoupilová Original Research Open access 18 March 2022 Pages: 839 - 850
An Observational Retrospective Matched Cohort Study of Healthcare Resource Utilisation and Costs in UK Patients with Moderate to Severe Osteoarthritis Pain Lucy AbrahamKate HalsbyHannah Stevenson Original Research Open access 21 March 2022 Pages: 851 - 874
Analysis of the Pharmacoutilization of Biological Drugs in Psoriatic Arthritis Patients: A Real-World Retrospective Study Among an Italian Population Valentina PerroneSerena LosiLuca Degli Esposti Original Research Open access 22 March 2022 Pages: 875 - 890
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers Amelia SpinellaMarco de PintoDilia Giuggioli Original Research Open access 25 March 2022 Pages: 891 - 905
Towards a Better Implementation of Treat-to-Target Strategy in Rheumatoid Arthritis: A Comparison of Two Real-World Cohorts Hong HuangWenhui XieZhuoli Zhang Original Research Open access 28 March 2022 Pages: 907 - 917
Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials Lihi EderHans-Peter TonyAlexis Ogdie Original Research Open access 09 April 2022 Pages: 919 - 933
Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications Joseph F. MerolaIain B. McInnesNehal N. Mehta Brief Report Open access 19 March 2022 Pages: 935 - 955
